− Treatment with Vutrisiran Led to 37- 49% Lower Rates of Gastrointestinal Events, a Multisystem Manifestation of ATTR-CM, Across Multiple Treatment Groups, Compared to Placebo – − Additional Analyses ...
A recent Sports Medicine – Open study conducted a randomized controlled trial to evaluate how varying carbohydrate intake and the glycemic index (GI) impact performance in endurance training regimens ...